Francis Knuettel II 4
4 · Chromocell Therapeutics Corp · Filed Feb 23, 2024
Insider Transaction Report
Form 4
Francis Knuettel II
CFO, Treas & Secty
Transactions
- Award
Employee Stock Option
2024-02-21−2,778→ 25,001 total(indirect: By LLC)Exercise: $22.68From: 2024-02-21Exp: 2033-01-10→ Common Stock (2,778 underlying)
Footnotes (2)
- [F1]The securities are held by Camden Capital LLC. The Reporting Person, as the manager of Camden Capital LLC, is deemed to be a beneficial owner of these securities.
- [F2]On January 10, 2023, Camden Capital LLC was granted stock options to purchase 2,778 shares of common stock at an exercise price of $22.68 per share, which became exercisable upon the closing of Issuer's initial public offering.